<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[61, 64] breathlessness at rest<br>[71, 74] breathlessness on exertion<br>[82, 85] quality of sleep<br>[97, 103] morning peak expiratory flow rate value<br>[150, 153] usage of bronchodilators<br></td>
<td width=33%>
[61, 64] breathlessness at rest<br>[71, 74] breathlessness on exertion<br>[82, 85] quality of sleep<br>[97, 103] morning peak expiratory flow rate value<br>[130, 133] treatment opinions,<br>[135, 137] treatment preferences<br>[150, 153] usage of bronchodilators<br>[162, 164] declined significantly<br>[179, 182] side-effects<br></td>
<td width=33%>
[61, 64] breathlessness at rest<br>[71, 74] breathlessness on exertion<br>[80, 85] and the quality of sleep<br>[95, 103] improving the morning peak expiratory flow rate value<br>[130, 137] treatment opinions, and their treatment preferences<br>[150, 164] usage of bronchodilators (theophylline and aerosol beta-stimulants combined) declined significantly<br>[178, 182] No side-effects<br>[208, 211] asthmatic symptoms,<br>[216, 223] amount of concomitant bronchodilator therapy required.<br></td>
</tr>
